CD52 expression in non-mycotic T- and NK/T-cell lymphomas.

CD52 expression in non-mycotic T- and NK/T-cell lymphomas.

Item
http://www.wikidata.org/entity/Q40239088
New molecular insights into peripheral T cell lymphomasOverview of alemtuzumab therapy for the treatment of T-cell lymphomas.The Outcome of HyperCVAD Combined with Alemtuzumab for the Treatment of Aggressive T-Cell and NK-Cell NeoplasmsAlemtuzumab in the treatment of chronic lymphocytic lymphoma.Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies.Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma).Targeted molecular therapy in peripheral T-cell lymphomas.Intensified alemtuzumab-CHOP therapy for peripheral T-cell lymphoma.CD52 expression in peripheral T-cell lymphomas determined by combined immunophenotyping using tumor cell specific T-cell receptor antibodies.Dose modification of alemtuzumab in combination with dexamethasone, cytarabine, and cisplatin in patients with relapsed or refractory peripheral T-cell lymphoma: analysis of efficacy and toxicity.
P2860

CD52 expression in non-mycotic T- and NK/T-cell lymphomas.

Item
http://www.wikidata.org/entity/Q40239088
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
CD52 expression in non-mycotic T- and NK/T-cell lymphomas.
@en
type
label
CD52 expression in non-mycotic T- and NK/T-cell lymphomas.
@en
prefLabel
CD52 expression in non-mycotic T- and NK/T-cell lymphomas.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
CD52 expression in non-mycotic T- and NK/T-cell lymphomas.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698